Effects of verteporfin-mediated photodynamic therapy in breast cancer cells

Simple item page
dc.contributor.authorSönmez P.K.
dc.contributor.authorTurhan A.
dc.contributor.authorÖztatlıcı M.
dc.contributor.authorÖzbilgin K.
dc.date.accessioned2024-07-22T08:07:07Z
dc.date.available2024-07-22T08:07:07Z
dc.date.issued2020
dc.description.abstractPhotodynamic therapy works with a photosensitizer that is stimulated when exposed to a light source of a specific wavelength and produces a form of oxygen that can be used in cancer treatments. In this study, we investigated the effect of laser on apoptosis on breast cancer cell lines (MDA-MB-231) treated with verteporfin in cell culture media. Verteporfin added MDA-MB-231 cells were incubated without light for 24 hours after applying laser light at a wavelength of 695 nm at an intensity of 50 J/cm2 at various times. Anti-proliferative effects were evaluated by immunoreactivity of anti-Bcl-2 and anti-Bax antibodies by immunocytochemical staining. When anti-Bax/Anti-Bcl-2 ratio are compared, the ratio of 1.5 in the control group cells decreases in short-term laser applications, while it approaches normal values in the 7th min after long-term laser application and reaches a very high value in the 9th min. Therefore, our results suggest that verteporfin-mediated PDT may be a potential combined therapy strategy against breast carcinoma by increasing apoptosis. © 2020, National Institute of Science Communication and Information Resources (NISCAIR). All rights reserved.
dc.identifier.issn03011208
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13841
dc.language.isoEnglish
dc.publisherNational Institute of Science Communication and Information Resources
dc.titleEffects of verteporfin-mediated photodynamic therapy in breast cancer cells
dc.typeArticle

Files

Collections

Scopus Koleksiyonu